350
Views
45
CrossRef citations to date
0
Altmetric
Original Research

Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study

, , , , &
Pages 1339-1350 | Published online: 22 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Tomiki Sumiyoshi, Hiroyuki Uchida, Koichiro Watanabe, Masato Oosawa, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder. Neuropsychiatric Disease and Treatment 18, pages 2507-2517.
Read now
Bernhard T Baune, Ioana Florea, Bjarke Ebert, Maëlys Touya, Anders Ettrup, Monica Hadi & Hongye Ren. (2021) Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study. Neuropsychiatric Disease and Treatment 17, pages 2995-3006.
Read now
Jun Ishigooka, Tatsuya Hoshino, Takumi Imai, Hisako Yoshida, Midori Ono, Mihoko Ota, Yoshiya Moriguchi, Keita Fujikawa, Ayumi Shintani & Jovelle L Fernandez. (2021) Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey. Neuropsychiatric Disease and Treatment 17, pages 2915-2924.
Read now
Tomiki Sumiyoshi, Koichiro Watanabe, Shinichi Noto, Shigeru Sakamoto, Yoshiya Moriguchi, Lene Hammer-Helmich & Jovelle Fernandez. (2021) Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J. Neuropsychiatric Disease and Treatment 17, pages 945-955.
Read now
Gang Wang, Kristin Hui Xian Tan, Hongye Ren & Lene Hammer-Helmich. (2020) Impact of Cognitive Symptoms on Health-Related Quality of Life and Work Productivity in Chinese Patients with Major Depressive Disorder: Results from the PROACT Study. Neuropsychiatric Disease and Treatment 16, pages 749-759.
Read now
Eric Armbrecht, Anuj Shah, Patricia Schepman, Ruchit Shah, Elizabeth Pappadopulos, Richard Chambers, Jennifer Stephens, Seema Haider & Roger S. McIntyre. (2020) Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States. Journal of Medical Economics 23:9, pages 1032-1042.
Read now
William Jacobson, Wei Zhong, George G. Nomikos, Michael Cronquist Christensen, Christina Kurre Olsen & Philip D. Harvey. (2020) Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis. Current Medical Research and Opinion 36:1, pages 117-124.
Read now
Kuniyoshi Toyoshima, Takeshi Inoue, Jiro Masuya, Masahiko Ichiki, Yota Fujimura & Ichiro Kusumi. (2019) Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults. Neuropsychiatric Disease and Treatment 15, pages 2981-2990.
Read now
Josep Maria Haro, Lene Hammer-Helmich, Delphine Saragoussi, Anders Ettrup & Klaus Groes Larsen. (2019) Patient-reported depression severity and cognitive symptoms as determinants of functioning in patients with major depressive disorder: a secondary analysis of the 2-year prospective PERFORM study. Neuropsychiatric Disease and Treatment 15, pages 2313-2323.
Read now
Qijing Bo, Lu Tian, Feng Li, Zhen Mao, Zhimin Wang, Xin Ma & Chuanyue Wang. (2019) Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder. Neuropsychiatric Disease and Treatment 15, pages 1649-1657.
Read now
Giulia Perini, Matteo Cotta Ramusino, Elena Sinforiani, Sara Bernini, Roberto Petrachi & Alfredo Costa. (2019) Cognitive impairment in depression: recent advances and novel treatments. Neuropsychiatric Disease and Treatment 15, pages 1249-1258.
Read now

Articles from other publishers (34)

Vicent-Gil M.Serra-Blasco M., Navarra-Ventura G.Trujols J.Balanzá-Martínez V.Portella MJ.Cardoner N.. (2022) In pursuit of full recovery in major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience 273:5, pages 1095-1104.
Crossref
Jing Yuan, Fang Sun, Xiaomin Zhao, Zejun Liu & Qing Liang. (2023) The relationship between mindfulness and mental health among Chinese college students during the closed-loop management of the COVID-19 pandemic: A moderated mediation model. Journal of Affective Disorders 327, pages 137-144.
Crossref
Caroline Kamp Jørgensen, Sophie Juul, Faiza Siddiqui, Mark Abie Horowitz, Joanna Moncrieff, Klaus Munkholm, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud & Janus Christian Jakobsen. (2023) The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis. Systematic Reviews 12:1.
Crossref
N. V. Stoyan, O. M. Ocheredko, V. O. Korobchanskyi, O. Yu. Bratkova & O. A. Serebrennikova. (2023) Adaptive capabilities of the body and aggressive personality manifestations of modern students at various stages of education in a higher education institution. Reports of Morphology 29:1, pages 24-33.
Crossref
Susana S Almeida, Michael Cronquist Christensen, Kenneth Simonsen & Michael Adair. (2022) Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study. Journal of Psychopharmacology 37:3, pages 279-288.
Crossref
Yuanyuan Wei, Jieqiong Cui, Chenyang Fu, Bonan Xu, Mingqin Shi, Youwu Dai, Xiaoyi Huang, Qingshan Hai, Anqi Ni, Bojun Chen, Lei Xiong & Dongdong Qin. (2023) Effects of Cang-Ai volatile oil on depressed mood and cortical excitability in human. Pharmacological Research - Modern Chinese Medicine 6, pages 100215.
Crossref
Elena Hernando-Merino, Enrique Baca-García & Maria Luisa Barrigón. (2022) A One-Year Follow Up Study on Disability in Mental Health Nursing Practice. Clinical Nursing Research 32:2, pages 384-392.
Crossref
Melexima Simirea, Cédric Baumann, Michael Bisch, Hélène Rousseau, Paolo Di Patrizio, Sarah Viennet & Stéphanie Bourion-Bédès. (2022) Health-related quality of life in outpatients with substance use disorder: evolution over time and associated factors. Health and Quality of Life Outcomes 20:1.
Crossref
Faith Matcham, Daniel Leightley, Sara Siddi, Femke Lamers, Katie M. White, Peter Annas, Giovanni de Girolamo, Sonia Difrancesco, Josep Maria Haro, Melany Horsfall, Alina Ivan, Grace Lavelle, Qingqin Li, Federica Lombardini, David C. Mohr, Vaibhav A. Narayan, Carolin Oetzmann, Brenda W. J. H. Penninx, Stuart Bruce, Raluca Nica, Sara K. Simblett, Til Wykes, Jens Christian Brasen, Inez Myin-Germeys, Aki Rintala, Pauline Conde, Richard J. B. Dobson, Amos A. Folarin, Callum Stewart, Yatharth Ranjan, Zulqarnain Rashid, Nick Cummins, Nikolay V. Manyakov, Srinivasan Vairavan & Matthew Hotopf. (2022) Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study. BMC Psychiatry 22:1.
Crossref
Monika Sadlonova, Julia Katharina Löser, Christopher M. Celano, Christina Kleiber, Daniel Broschmann & Christoph Herrmann-Lingen. (2022) Changes in treatment outcomes in patients undergoing an integrated psychosomatic inpatient treatment: Results from a cohort study. Frontiers in Psychiatry 13.
Crossref
Saundra Jain, Shaloo Gupta, Vicky W. Li, Ellison Suthoff & Alix Arnaud. (2022) Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis. BMC Psychiatry 22:1.
Crossref
Thida Mulalint, Acharaporn Seeherunwong, Napaporn Wanitkun & Sasima Tongsai. (2022) Determinants of continuing mental health service use among older persons diagnosed with depressive disorders in general hospitals: latent class analysis and GEE. BMC Health Services Research 22:1.
Crossref
Darawan Wongprommate, Tinakon Wongpakaran, Manee Pinyopornpanish, Peerasak Lerttrakarnnon, Surin Jiraniramai, Sirina Satthapisit, Nattha Saisavoey, Kamonporn Wannarit, Daochompu Nakawiro, Thanita Tantrarungroj & Nahathai Wongpakaran. (2021) Predictors for quality of life among older adults with depressive disorders: A prospective 3‐month follow‐up cohort study. Perspectives in Psychiatric Care 58:3, pages 1029-1036.
Crossref
Shinichi Noto, Mayumi Wake, Izumi Mishiro, Lene Hammer-Helmich, Hongye Ren, Yoshiya Moriguchi, Keita Fujikawa & Jovelle Fernandez. (2022) Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy. Value in Health Regional Issues 30, pages 127-133.
Crossref
Anton A. Abramkin, Tatiana A. Lisitsyna, Dmitry Yu. Veltishchev, Olga F. Seravina, Oksana B. Kovalevskaya, Svetlana I. Glukhova & Evgeny L. Nasonov. (2022) Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis. Terapevticheskii arkhiv 94:5, pages 616-621.
Crossref
Fareeda Abo-Rass, Perla Werner & Shiri Shinan-Altman. (2021) Cognitive illness representations among Israeli Arabs diagnosed with depression and their relationship with health-related quality of life. International Journal of Social Psychiatry 68:3, pages 582-588.
Crossref
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A. Katzman, Mircea Polosan, Kenneth Simonsen & Lene Hammer-Helmich. (2022) Effectiveness of Vortioxetine in Patients With Major Depressive Disorder in Real-World Clinical Practice: Results of the RELIEVE Study. Frontiers in Psychiatry 13.
Crossref
Andreea Sălcudean, Elena-Gabriela Strete, Monica Kiss, Maria-Dorina Pașca, Cristina-Raluca Bodo, Maria-Melania Cozma, Andreea-Georgiana Nan, Marius-Cătălin Cosma & Răzvan-Andrei Teslaru. (2022) Evolutive Pattern of Major Depressive Disorder among Young Patients. Journal of Interdisciplinary Medicine 7:1, pages 8-12.
Crossref
Jieun Kim, Juhui Han & Byung Chul Chun. (2022) Trends of Internet Search Volumes for Major Depressive Disorder Symptoms During the COVID-19 Pandemic in Korea: An Interrupted Time-Series Analysis. Journal of Korean Medical Science 37:14.
Crossref
Faiza Siddiqui, Marija Barbateskovic, Sophie Juul, Kiran Kumar Katakam, Klaus Munkholm, Christian Gluud & Janus Christian Jakobsen. (2021) Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Systematic Reviews 10:1.
Crossref
James Brockbank, Taryn Krause, Emily Moss, Anne Milthers Pedersen, Michael Frank Mørup, Outi Ahdesmäki, Jake Vaughan & Thor-Henrik Brodtkorb. (2021) Health state utility values in major depressive disorder treated with pharmacological interventions: a systematic literature review. Health and Quality of Life Outcomes 19:1.
Crossref
Heidemarie Lex, Steven W. Nevers, Erica L. Jensen, Yarden Ginsburg, Daniel F. Maixner & Brian J. Mickey. (2021) Long-term quality of life in treatment-resistant depression after electroconvulsive therapy. Journal of Affective Disorders 291, pages 135-139.
Crossref
Amelia M. Stanton, Jasper S. Lee, Megan R. Wirtz, Lena S. Andersen, John Joska, Steven A. Safren, Richard van Zyl-Smit & Conall O’Cleirigh. (2021) Tobacco Use and Health-Related Quality of Life Among Individuals with Depression Who Are Receiving Treatment for HIV in Cape Town, South Africa. International Journal of Behavioral Medicine 28:4, pages 417-430.
Crossref
Shannon Cochrane, Ann Marie Dale, Skye Buckner-Petty, Andrew D. Sobel, Brandon Lippold & Ryan P. Calfee. (2021) Relevance of Diagnosed Depression and Antidepressants to PROMIS Depression Scores Among Hand Surgical Patients. The Journal of Hand Surgery 46:2, pages 99-105.
Crossref
Fareeda Abo-Rass, Shiri Shinan-Altman & Perla Werner. (2020) Health-related quality of life among Israeli Arabs diagnosed with depression: the role of illness representations, self-stigma, self-esteem, and age. Journal of Affective Disorders 274, pages 282-288.
Crossref
Xin Ye, Hui-Ling Shu, Xia Feng, Deng-mei Xia, Zheng-qun Wang, Wen-yao Mi, Bei Yu, Xue-li Zhang & Changqiang Li. (2020) Reliability and validity of the Chinese version of the Patient Health Questionnaire-9 (C-PHQ-9) in patients with psoriasis: a cross-sectional study. BMJ Open 10:7, pages e033211.
Crossref
Michael Cronquist Christensen, Chiew Meng Johnny Wong & Bernhard T. Baune. (2020) Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?. Frontiers in Psychiatry 11.
Crossref
Charles Cotrena, Laura Damiani Branco, Flávio Milman Shansis & Rochele Paz Fonseca. (2020) Predictors of quality of life in bipolar disorder: A path analytical study. Psychiatry Research 285, pages 112846.
Crossref
Tanja Grahovac Juretić, Marina Letica-Crepulja, Aleksandra Stevanović, Klementina Ružić, Ika Rončević-Gržeta & Ana Došen. (2020) The effects of psychosocial day care program on clinical symptoms and quality of life of persons with depression: a prospective study. The European Journal of Psychiatry 34:1, pages 27-35.
Crossref
Tracy L. Greer & Jeethu K. Joseph. 2020. Major Depressive Disorder. Major Depressive Disorder 131 146 .
Pratap Chokka, Joanna Bougie, Jean Proulx, Anders Holmegaard Tvistholm & Anders Ettrup. (2019) Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: results from the AtWoRC study. CNS Spectrums 24:6, pages 616-627.
Crossref
Tomiki Sumiyoshi, Koichiro Watanabe, Shinichi Noto, Shigeru Sakamoto, Yoshiya Moriguchi, Kristin Hui Xian Tan, Lene Hammer-Helmich & Jovelle Fernandez. (2019) Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross–sectional analysis of baseline data from PERFORM-J. Journal of Affective Disorders 258, pages 172-178.
Crossref
Bernhard T. Baune & Michael Cronquist Christensen. (2019) Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression. Frontiers in Psychiatry 10.
Crossref
Michael Cronquist Christensen, Lasse Breuning Sluth & Roger S. McIntyre. (2019) Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings. Journal of Affective Disorders 245, pages 508-516.
Crossref